Insider Selling: Mednax SVP Sells 3,718 Shares of Stock (MD)
Mednax (NYSE:MD) SVP Dominic Andreano sold 3,718 shares of Mednax stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $99.63, for a total transaction of $370,424.34. Following the completion of the sale, the senior vice president now directly owns 9,568 shares in the company. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on MD. Analysts at Credit Suisse raised their price target on shares of Mednax (NYSE:MD) from $90.00 to $97.00 in a research note to investors on Thursday, August 1st. They now have a “neutral” rating on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of Mednax (NYSE:MD) from $100.00 to $112.00 in a research note to investors on Wednesday, July 31st. They now have an “overweight” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Mednax (NYSE:MD) in a research note to investors on Monday, July 8th. They set a “market perform” rating on the stock. They noted that the move was a valuation call.
Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Mednax currently has an average rating of “Hold” and an average price target of $94.89.
Shares of Mednax (NYSE:MD) traded up 0.36% during mid-day trading on Thursday, hitting $101.22. 265,843 shares of the company’s stock traded hands. Mednax has a 52 week low of $67.86 and a 52 week high of $100.97. The stock’s 50-day moving average is $97.98 and its 200-day moving average is $91.69. The company has a market cap of $5.016 billion and a price-to-earnings ratio of 19.71.
Mednax (NYSE:MD) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.37 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.36 by $0.01. The company had revenue of $529.18 million for the quarter, compared to the consensus estimate of $533.39 million. During the same quarter last year, the company posted $1.22 earnings per share. Mednax’s revenue was up 17.7% compared to the same quarter last year. On average, analysts predict that Mednax will post $5.46 earnings per share for the current fiscal year.
MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.